Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
The in vitro activity of BMY-28142, a new cephalosporin, was tested by a broth microdilution system and compared with those of cefotaxime, ceftazidime, cefoperazone, moxalactam, and HR 810 against 747 bacterial isolates, one-third of which were resistant to one or more third-generation cephalosporin...
Shranjeno v:
| izdano v: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1985
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180130/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3893316/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.5.679 |
| Oznake: |
Brez oznak, prvi označite!
|